← Back to Patent Explorer
US3329567A Expired / Lapsed US ⏱️ 0.0 years remaining

Synergistic effect of adenylic nucleotides in digitalis therapy

Assignee: Union Carbide Corp
•
Filing: 1963-09-16
•
Granted: 1967-07-04
•
Expires: 1983-09-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Farhi Carol
  • 👤 Dan B Ruskin
  • 👤 Reder Milton

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 08:37
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7088; A61K31/7028; A61K31/7034; A61K31/704; A61K36/00; A61K36/18; A61K36/185; A61K36/80

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 90 words
A THERAPEUTIC COMPOSITION PREPARED FOR ADMINISTRATION INTO THE HUMAN ORGANISM COMPRISING A PHARMACEUTICAL CARRIER AND AS THE ACTIVE AGENTS THEREIN AN ADENYLIC NUCLEOTIDE SELECTED FROM THE GROUP CONSISTING OF NICOTINAMIDE ADENYLATE AND PROCAINE ADENYLATE, IN COMBINATION WITH A DIGITALIS PREPARATION SELECTED FROM THE GROUP CONSISTING OF WHOLE-LEAF DIGITALIS AND PURIFIED GLYCOSIDE DERIVATIVES THEREOF, SAID DIGITALIS PREPARATION BEING PRESENT IN AN AMOUNT PER DOSAGE UNIT WHICH IS SUBSTANTIALLY BELOW THE TOLERANCE LEVEL FOR TOXIC MANIFESTATIONS RESULTING THEREFROM; SAID COMPOSITION BEING EFFECTIVE IN THE TREATMENT OF NON-INFLAMMATORY CARDIAC ABNORMALITIES AND MYOCARDIAL DISORDERS.
Claim 2
Dependent Claim 90 words
A THERAPEUTIC COMPOSITION PREPARED FOR ADMINISTRATION INTO THE HUMAN ORGANISM COMPRISING A PHARMACEUTICAL CARRIER AND AS THE ACTIVE AGENTS THEREIN AN ADENYLIC NUCLEOTIDE SELECTED FROM THE GROUP CONSISTING OF NICOTINAMIDE ADENYLATE AND PROCAINE ADENYLATE, IN COMBINATION WITH A DIGITALIS PREPARATION SELECTED FROM THE GROUP CONSISTING OF WHOLE-LEAF DIGITALIS AND PURIFIED GLYCOSIDE DERIVATIVES THEREOF, SAID DIGITALIS PREPARATION BEING PRESENT IN AN AMOUNT PER DOSAGE UNIT WHICH IS SUBSTANTIALLY BELOW THE TOLERANCE LEVEL FOR TOXIC MANIFESTATIONS RESULTING THEREFROM; SAID COMPOSITION BEING EFFECTIVE IN THE TREATMENT OF NON-INFLAMMATORY CARDIAC ABNORMALITIES AND MYOCARDIAL DISORDERS.

References Cited (Backward Citations)

US3104203A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1970-07-03 1971-01-02 1971-07-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1974-07-03 1975-01-02 1975-07-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1978-07-03 1979-01-02 1979-07-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag